Estrogen receptor β mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation

Cardiovascular Research

Volumn 59, Issue 3, 2003, Pages 734-744

  Watanabe, Tokumitsu ^a   Akishita, Masahiro ^b   Nakaoka, Takashi ^c   Kozaki, Koichi ^a   Miyahara, Yukiko ^a   He, Hong ^a   Ohike, Yumiko ^a   Ogita, Teruhiko ^c   Inoue, Satoshi ^a   Muramatsu, Masami ^d   Yamashita, Naohide ^c   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Gene expression; Hormones; Receptors; Smooth muscle

Indexed keywords

ADENOVIRUS VECTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSFECTION; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOTTING, NORTHERN; CELL DIVISION; CELLS, CULTURED; CYCLIN A; DEPRESSION, CHEMICAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENETIC VECTORS; LUCIFERASES; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC;

EID: 12144289305     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00496-6     Document Type: Article

References (39)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
2. Bush T.L., Barrett-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75:1987;1102-1109.
3. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. New Engl J Med. 325:1991;756-762.
4. Hisamoto K., Ohmichi M., Kurachi H., et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem. 276:2001;3459-3467.
5. Akishita M., Ouchi Y., Miyoshi H., et al. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis. 130:1997;1-10.
6. Morey A.K., Pedram A., Razandi M., et al. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology. 138:1997;3330-3339.
7. Dubey R.K., Gillespie D.G., Mi Z., et al. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway. Hypertension. 35:2000;262-266.
8. Dubey R.K., Jackson E.K., Gillespie D.G., et al. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol. 20:2000;964-972.
9. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288:2002;321-333.
10. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J. Am. Med. Assoc. 280:1998;605-613.
11. Teede H.J., McGrath B.P., Smolich J.J., et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol. 20:2000;1404-1409.
12. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 93:1996;5925-5930.
13. Giguere V., Tremblay A., Tremblay G.B. Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. Steroids. 63:1998;335-339.
14. Altucci L., Addeo R., Cicatiello L., et al. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene. 12:1996;2315-2324.
15. Ernst M., Heath J.K., Schmid C., Froesch R.E., Rodan G.A. Evidence for a direct effect of estrogen on bone cells in vitro. J Steroid Biochem. 34:1989;279-284.
16. Orimo A., Inoue S., Ikegami A., et al. Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun. 195:1993;730-736.
17. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 89:1994;1943-1950.
18. Hodges Y.K., Tung L., Yan X.D., et al. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation. 101:2000;1792-1798.
19. Iafrati M.D., Karas R.H., Aronovitz M., et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med. 3:1997;545-548.
20. Karas R.H., Hodgin J.B., Kwoun M., et al. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci USA. 96:1999;15133-15136.
21. Karas R.H., Schulten H., Pare G., et al. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res. 89:2001;534-539.
22. Pare G., Krust A., Karas R.H., et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res. 90:2002;1087-1092.
23. Lindner V., Kim S.K., Karas R.H., et al. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res. 83:1998;224-229.
24. Watanabe T., Yoshizumi M., Akishita M., et al. Induction of nuclear orphan receptor NGFI-B gene and apoptosis in rat vascular smooth muscle cells treated with pyrrolidinedithiocarbamate. Arterioscler Thromb Vasc Biol. 21:2001;1738-1744.
25. Ogawa S., Inoue S., Orimo A., et al. Cross-inhibition of both estrogen receptor alpha and beta pathways by each dominant negative mutant. FEBS Lett. 423:1998;129-132.
26. Nakaoka T., Gonda K., Ogita T., et al. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest. 100:1997;2824-2832.
27. Ohyama K.I., Nagai F., Tsuchiya Y. Certain styrene oligomers have proliferative activity on MCF-7 human breast tumor cells and binding affinity for human estrogen receptor. Environ Health Perspect. 109:2001;699-703.
28. Inoue K., Okumura H., Higuchi T., et al. Characterization of estrogenic compounds in medical polyvinyl chloride tubing by gas chromatography-mass spectrometry and estrogen receptor binding assay. Clin Chim Acta. 325:2002;157-163.
29. Jones P.S., Parrott E., White I.N. Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent. J Biol Chem. 274:1999;32008-32014.
30. Lazennec G., Alcorn J.L., Katzenellenbogen B.S. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Mol Endocrinol. 13:1999;969-980.
31. Lazennec G., Bresson D., Lucas A., Chauveau C., Vignon F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology. 142:2001;4120-4130.
32. Lee E.J., Duan W.R., Jakacka M., Gehm B.D., Jameson J.L. Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology. 142:2001;3756-3763.
33. Paech K., Webb P., Kuiper G.G., et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1997;1508-1510.
34. Paige L.A., Christensen D.J., Gron H., et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci USA. 96:1999;3999-4004.
35. Poelzl G., Kasai Y., Mochizuki N., et al. Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2. Proc Natl Acad Sci USA. 97:2000;2836-2839.
36. Liu M.M., Albanese C., Anderson C.M., et al. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem. 277:2002;24353-24360.
37. Girard F., Strausfeld U., Fernandez A., Lamb N.J. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 67:1991;1169-1179.
38. Takeda-Matsubara Y., Nakagami H., Iwai M., et al. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension. 39:2002;41-45.
39. Andersson C., Lydrup M.L., Ferno M., et al. Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat. J Endocrinol. 169:2001;241-247.